Metrics as of 10/14/2026, 07:27 PM (Berlin time), refresh in progress.
Allarity Therapeutics Stock
Allarity Therapeutics, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Thomas H. Jensen
- Employees
- 8
- Market cap
- $14 M
- IPO
- 21/12/2021
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The…
Allarity Therapeutics stock: price history
1D
+7.5%
1W
-9.6%
1M
-22.8%
6M
-27.2%
YTD
-17.1%
1Y
-38.3%
2Y
-46.4%
5Y
–
10Y
–
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~13% weaker price swings than usual
Ask the agents about Allarity Therapeutics
Analyst assessment of Allarity Therapeutics
0
STRONG BUY
1
BUY
1
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 16/09/2026
Allarity Therapeutics stock metrics
P/E
-1.15
P/B
4.03
EV/EBITDA
-1.74
RETURN ON EQUITY
-96.3%
NET MARGIN
0.0%
DEBT/EQUITY
6.3
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
76.3%
FLOAT SHARES
12,136,952
AVG. DAILY VOLUME (30D)
134,492
Insider transactions (SEC)
Graff Jeremy R.
Graff Jeremy R.
Graff Jeremy R.
Graff Jeremy R.
Jensen Thomas
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Allarity Therapeutics stock
What does Allarity Therapeutics do?
Allarity Therapeutics, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Thomas H. Jensen, the company employs around 8 people.
The IPO was on 21/12/2021; the stock trades on NASDAQ under the ticker ALLR.
What do analysts say about Allarity Therapeutics stock?
2 analysts rate the stock, the consensus is Buy (as of 16/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Allarity Therapeutics report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly -13% stronger than usual.
Does Allarity Therapeutics pay a dividend?
No, Allarity Therapeutics currently does not pay a dividend.
Which stocks are comparable to Allarity Therapeutics?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Allarity Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Allarity Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.